This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (8)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Oncology  • Head & Neck Cancer  • Genetics of Head & Neck Disease  • Neoplasms of Head & Neck  • Pathology of Head & Neck  • Alert me on articles by topic

Arch Otolaryngol Head Neck Surg. 2003;129:363-366.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hypothesis: Genetic markers are not currently useful in the clinical care of patients with head and neck cancer.

BACKGROUND

During the past few years, there has been an explosion in the number of articles investigating genetic markers and head and neck cancer. This is interesting for the scientist but confusing for the clinician. It is difficult to decipher the utility of the "alphabet soup" of molecular markers found in the literature. The genes described are unfamiliar to most otolaryngologists treating patients with head and neck cancer, and the articles are confounded by conflicting data.

Figure appears in full text version. Paul L. Friedlander, MD

The investigation of molecular markers of head and neck cancers is certainly intellectually challenging. The real question for the clinician is, Will these data translate into improvements in locoregional control and survival? The present article will investigate the current clinical utility of molecular markers and comment on the hypothesis that these markers are . . . [Full Text of this Article]

PRO

CON

BOTTOM LINE

RELATED ARTICLES

Genetic Markers of Head and Neck Cancer: Identifying New Molecular Targets
Carol R. Bradford
Arch Otolaryngol Head Neck Surg. 2003;129(3):366-367.
EXTRACT | FULL TEXT  

Genetic Markers in the Clinical Care of Head and Neck Cancer: Slow in Coming
Wayne Koch
Arch Otolaryngol Head Neck Surg. 2003;129(3):367-368.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

FDG-PET Prediction of Head and Neck Squamous Cell Cancer Outcomes
Schwartz et al.
Arch Otolaryngol Head Neck Surg 2004;130:1361-1367.
ABSTRACT | FULL TEXT